e-learning
resources
Stockholm 2002
Sunday 15.09.2002
The development of allergic sensitization / asthma in children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The eosinophil cationic protein/eosinophil count ratio as a marker of asthma in children
I. Stelmach, M. Bobrowska, W. Stelmach, A. Brzozowska, J. Jerzynska, P. Kuna (Zgierz, Lodz, Poland)
Source:
Annual Congress 2002 - The development of allergic sensitization / asthma in children
Session:
The development of allergic sensitization / asthma in children
Session type:
Thematic Poster Session
Number:
775
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Stelmach, M. Bobrowska, W. Stelmach, A. Brzozowska, J. Jerzynska, P. Kuna (Zgierz, Lodz, Poland). The eosinophil cationic protein/eosinophil count ratio as a marker of asthma in children. Eur Respir J 2002; 20: Suppl. 38, 775
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Comparisons of the eosinophil cationic protein (ECP) levels and eosinophil counts in sputum of mustard lung disease (MLD) and normal subjects
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015
The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 268s
Year: 2001
FE
NO
and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Theophylline drip infusion reduces peripheral blood eosinophil counts and ECP (eosinophil cationic protein) level on acute exacerbation of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 108s
Year: 2002
Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Mycoplasma pneumoniae
infection affects total eosinophil count, the serum level of ECP, and interleukin-5 in atopic children
Source: Annual Congress 2012 - Airway infections in children: from risk factors to treatment
Year: 2012
Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients?
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients?
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
BAL eosinophil counts and specific clinical phenotypes of asthmatic and/or atopic children
Source: Annual Congress 2011 - Flexible bronchoscopy in the diagnosis of paediatric lung diseases
Year: 2011
Definition of COPD phenotype depending on eosinophil count
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Changes in eosinophil count and C reactive protein following treatment with mebendazole in patients with Toxocara-associated asthma
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010
A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Blood eosinophil counts and degree of allergen sensitization as age dependent correlations in children with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 452s
Year: 2001
A low total sputum cell count is a marker for asthma remission during adolescence
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012
Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept